King Rachel K.
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to King Rachel K.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NVAX | Option Exercise | 10,420 | — | — | Jun 12, 2025 | |
| NVAX | Sale | 4,150 | $9.02 | $37,433 | Dec 13, 2024 | |
| NVAX | Option Exercise | 6,670 | — | — | Jun 12, 2024 | |
| CBIO | Award / Grant | 3,334 | $3.00 | $10,002 | Mar 29, 2024 | |
| CBIO | Award / Grant | 4,238 | $2.36 | $10,002 | Dec 29, 2023 | |
| CBIO | Award / Grant | 6,667 | $1.50 | $10,001 | Sep 30, 2023 | |
| NVAX | Option Exercise | 3,100 | — | — | Jun 10, 2023 | |
| CBIO | W | 11,641 | — | — | Aug 2, 2022 | |
| NVAX | Option Exercise | 700 | — | — | Jun 17, 2022 | |
| NVAX | Option Exercise | 6,900 | — | — | Jun 25, 2021 | |
| NVAX | Option Exercise | 3,450 | — | — | Jun 25, 2021 | |
| NVAX | Purchase | 700 | $139.64 | $97,748 | May 19, 2021 | |
| CBIO | President, CEO | Award / Grant | 96,250 | — | — | Jan 20, 2021 |
| CBIO | President, CEO | Option Exercise | 130,821 | $1.12 | $146,520 | Dec 28, 2020 |
| CBIO | President, CEO | Option Exercise | 166,759 | $1.12 | $186,770 | Aug 6, 2019 |
| NVAX | Purchase | 22,000 | $0.53 | $11,660 | Mar 27, 2019 | |
| CBIO | President, CEO | Gift | 23,301 | — | — | Sep 8, 2017 |
| CBIO | President, CEO | Option Exercise | 50,000 | $1.12 | $56,000 | Feb 24, 2015 |
| CBIO | President, CEO | Option Exercise | 100,000 | $1.12 | $112,000 | Jun 18, 2014 |